News about "GLP-1 receptor agonists "

PrecisionLife and Ovation Partner to Launch GLP-1 stratification LDT and GLP-1 DNA Test in H2 2026

PrecisionLife and Ovation Partner to Launch GLP-1 stratification LDT and GLP-1 DNA Test in H2 2026

PrecisionLife and Ovation partner to launch GLP-1 stratification LDT and consumer DNA test in 2026, with early data showing distinct genetic markers for weight loss and glycemic control.

GLP-1 Receptor Agonists | 16/04/2026 | By News Bureau

Yao Pharma and Pfizer Sign Exclusive Collaboration Deal

Yao Pharma and Pfizer Sign Exclusive Collaboration Deal

Yao Pharma has entered into an exclusive global licensing agreement with Pfizer, granting rights to develop, manufacture, and commercialise its oral small-molecule GLP-1 receptor agonists, including lead candidate YP05002. The partnership aims to advance next-generation metabolic therapies with worldwide reach.

GLP-1 Receptor Agonists | 10/12/2025 | By Akanki 131

BioMed X and Novo Nordisk Partner to Advance Oral Peptide Drug Delivery

BioMed X and Novo Nordisk Partner to Advance Oral Peptide Drug Delivery

BioMed X and Novo Nordisk’s partnership aims to address one of the most critical challenges in modern drug development: the efficient oral delivery of therapeutic peptides.

GLP-1 Receptor Agonists | 21/08/2025 | By Dineshwori 618


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members